CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-020-00985-5
Abstract: We read with interest the cost-effectiveness study by Narasimhalu et al. [1], which evaluated the cost effectiveness of CYP2C19 genotype-guided antiplatelet therapy in an Asian population of patients presenting with acute ischaemic stroke with the… read more here.
Keywords: cyp2c19 genotype; antiplatelet therapy; genotype; guided antiplatelet ... See more keywords
Genotype-guided antiplatelet therapy compared with conventional therapy for patients with acute coronary syndromes: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2019 at "Biomarkers"
DOI: 10.1080/1354750x.2019.1634764
Abstract: Abstract To evaluate whether genotype-guided antiplatelet therapy reduces the rates of cardiovascular events and bleeding events in patients with acute coronary syndrome (ACS). We systematically searched Pubmed, Embase and the Cochrane Central Register of Controlled… read more here.
Keywords: therapy; guided antiplatelet; genotype guided; antiplatelet therapy ... See more keywords
The effect of CYP2C19 genotype-guided antiplatelet therapy on outcomes of selective percutaneous coronary intervention patients: an observational study.
Sign Up to like & getrecommendations! Published in 2019 at "Personalized medicine"
DOI: 10.2217/pme-2018-0087
Abstract: Aim: To observe if personalized antiplatelet therapy according to the CYP2C19 phenotype can improve the outcomes of patients receiving selective percutaneous coronary intervention (PCI). Methods: In this observational study, 677 Chinese patients undergoing selective PCI… read more here.
Keywords: therapy; antiplatelet therapy; guided antiplatelet; cyp2c19 genotype ... See more keywords